Gilad Glick

Chairman of the board

Gilad Glick is currently Vice President, Venture Investments for Johnson & Johnson Innovation Fund heading the activity in Israel for both (Bio)Pharma and MedTech and Europe for MedTech. Prior to that he led Itamar Medical as CEO, a sleep apnea diagnostic and digital care pathway publicly traded company (TASE, NASDAQ) for over 8 years before it was sold to ZOLL Medical , a world leader in the cardiac defibrillation market in late 2021. Prior to joining Itamar Medical in 2013, Gilad had an 17-year career in medical devices spanning a number of countries in Europe and the US and in a variety of functional areas including sales, marketing, service and research and development all with Johnson & Johnson . In his last role Gilad served as Vice President Global Sales and Marketing for Biosense Webster, a Johnson & Johnson company, at the time a $1.5B revenue operating company which oversees all strategic and commercial activities.

Gilad is a 8400 Heath Network member graduating cohort 4 , a founder of the MedTech Commercialization Institute and a Board of Directors member at Beta Bionics (Private).

Gilad holds Master of Business Administration, Major in General and Strategic Management from Maastricht School of Management, Maastricht, The Netherlands.

Other QUALIFICATIONS

November 2021 – Life Science Executive Program – Harvard Business School
2021 – Current : member and mentor 8400 Health Network (graduate Cohort # 4)
Founder and president– Non Profit MedTech Commercialization Institute - help MedTech startups plan for successful commercialization early
May 2010 – Sept 2010, Johnson & Johnson Accelerated Enterprise Leadership (LeAD) Process
January – May 2006, Johnson & Johnson Business Excellence Six Sigma Black Belt Certification.
August 14 – 24 2005, Stanford Graduate School of Business, Stanford, CA.-“Strategic Marketing Management Program (SMM)”
May 2004, PCI Global Inc, Diamond Bar, CA
October 2003, Dr. Michael Watkins, Harvard Business School, Johnson & Johnson, New Jersey.
Johnson & Johnson Transition Leadership Forum